GB0402797D0 - Organic compounds - Google Patents

Organic compounds

Info

Publication number
GB0402797D0
GB0402797D0 GBGB0402797.5A GB0402797A GB0402797D0 GB 0402797 D0 GB0402797 D0 GB 0402797D0 GB 0402797 A GB0402797 A GB 0402797A GB 0402797 D0 GB0402797 D0 GB 0402797D0
Authority
GB
United Kingdom
Prior art keywords
organic compounds
compounds
organic
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB0402797.5A
Other languages
English (en)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Novartis AG
Original Assignee
Novartis AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novartis AG filed Critical Novartis AG
Priority to GBGB0402797.5A priority Critical patent/GB0402797D0/en
Publication of GB0402797D0 publication Critical patent/GB0402797D0/en
Priority to TW094103838A priority patent/TW200536533A/zh
Priority to RU2006132195/15A priority patent/RU2006132195A/ru
Priority to CNA2005800044314A priority patent/CN1917875A/zh
Priority to EP05707254A priority patent/EP1715860A1/fr
Priority to KR1020067016003A priority patent/KR20060127974A/ko
Priority to JP2006551821A priority patent/JP2007522141A/ja
Priority to PCT/EP2005/001241 priority patent/WO2005074924A1/fr
Priority to AU2005210140A priority patent/AU2005210140A1/en
Priority to CA002552938A priority patent/CA2552938A1/fr
Priority to BRPI0507544-0A priority patent/BRPI0507544A/pt
Priority to PE2005000154A priority patent/PE20050692A1/es
Priority to ARP050100452A priority patent/AR047962A1/es
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A61K31/428—Thiazoles condensed with carbocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A61K31/573—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone substituted in position 21, e.g. cortisone, dexamethasone, prednisone or aldosterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/58—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Pulmonology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
GBGB0402797.5A 2004-02-09 2004-02-09 Organic compounds Ceased GB0402797D0 (en)

Priority Applications (13)

Application Number Priority Date Filing Date Title
GBGB0402797.5A GB0402797D0 (en) 2004-02-09 2004-02-09 Organic compounds
TW094103838A TW200536533A (en) 2004-02-09 2005-02-05 Organic compounds
BRPI0507544-0A BRPI0507544A (pt) 2004-02-09 2005-02-08 combinação de agonistas de benzotiazol-2-ona beta-2 adrenoreceptores e corticosteróides para o tratamento de doenças respiratórias
JP2006551821A JP2007522141A (ja) 2004-02-09 2005-02-08 呼吸器疾患の処置のためのベンゾチアゾール−２−オンベータ２アドレナリン受容体アゴニストとコルチコステロイドの組合せ剤
CNA2005800044314A CN1917875A (zh) 2004-02-09 2005-02-08 治疗呼吸疾病的苯并噻唑－2－酮β2肾上腺素受体激动剂与皮质类固醇的组合
EP05707254A EP1715860A1 (fr) 2004-02-09 2005-02-08 Combinaison d'agonistes de l'adrenorecepteur beta2 de la benzothiazol-2-one et de corticosteroides dans le traitement des maladies respiratoires
KR1020067016003A KR20060127974A (ko) 2004-02-09 2005-02-08 호흡기 질환의 치료를 위한 벤조티아졸-2-온 베타2아드레날린 수용체 효능제 및 코르티코스테로이드의 조합물
RU2006132195/15A RU2006132195A (ru) 2004-02-09 2005-02-08 Комбинация агонистов бета-2 адренорецептора, бензотиазол-2-онов и кортикостероидов, предназначенная для лечения респираторных заболеваний
PCT/EP2005/001241 WO2005074924A1 (fr) 2004-02-09 2005-02-08 Combinaison d'agonistes de l'adrenorecepteur beta2 de la benzothiazol-2-one et de corticosteroides dans le traitement des maladies respiratoires
AU2005210140A AU2005210140A1 (en) 2004-02-09 2005-02-08 Combination of benzothiazol-2-one beta2 adrenoceptor agonists and corticosteroids for the treatment of respiratory diseases
CA002552938A CA2552938A1 (fr) 2004-02-09 2005-02-08 Combinaison d'agonistes de l'adrenorecepteur beta2 de la benzothiazol-2-one et de corticosteroides dans le traitement des maladies respiratoires
PE2005000154A PE20050692A1 (es) 2004-02-09 2005-02-09 Compuestos organicos
ARP050100452A AR047962A1 (es) 2004-02-09 2005-02-09 Combinacion de agonistas de adrenoceptor beta-2 y corticosteroides para el tratamiento de enfermedades respiratorias

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB0402797.5A GB0402797D0 (en) 2004-02-09 2004-02-09 Organic compounds

Publications (1)

Publication Number Publication Date
GB0402797D0 true GB0402797D0 (en) 2004-03-10

Family

ID=31985893

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB0402797.5A Ceased GB0402797D0 (en) 2004-02-09 2004-02-09 Organic compounds

Country Status (13)

Country Link
EP (1) EP1715860A1 (fr)
JP (1) JP2007522141A (fr)
KR (1) KR20060127974A (fr)
CN (1) CN1917875A (fr)
AR (1) AR047962A1 (fr)
AU (1) AU2005210140A1 (fr)
BR (1) BRPI0507544A (fr)
CA (1) CA2552938A1 (fr)
GB (1) GB0402797D0 (fr)
PE (1) PE20050692A1 (fr)
RU (1) RU2006132195A (fr)
TW (1) TW200536533A (fr)
WO (1) WO2005074924A1 (fr)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW200738658A (en) 2005-08-09 2007-10-16 Astrazeneca Ab Novel compounds
TW200740781A (en) * 2005-08-29 2007-11-01 Astrazeneca Ab Novel compounds
TW200738659A (en) * 2005-08-29 2007-10-16 Astrazeneca Ab Novel compounds
JP5257073B2 (ja) * 2005-11-10 2013-08-07 ボーダー、ニコラス・エス ソフト型抗コリン作動性エステル
GB0601951D0 (en) 2006-01-31 2006-03-15 Novartis Ag Organic compounds
TW200745067A (en) * 2006-03-14 2007-12-16 Astrazeneca Ab Novel compounds
TW200833670A (en) 2006-12-20 2008-08-16 Astrazeneca Ab Novel compounds 569
GB0702458D0 (en) 2007-02-08 2007-03-21 Astrazeneca Ab Salts 668
GB0702456D0 (en) * 2007-02-08 2007-03-21 Astrazeneca Ab New combination
EP2011534A1 (fr) * 2007-07-03 2009-01-07 CHIESI FARMACEUTICI S.p.A. Actionneur d'inhalateur à dosage mesuré
ES2399945T3 (es) 2007-11-30 2013-04-04 Pfizer Limited Agonistas novedosos de los receptores de glucocorticoides
CA2709071C (fr) 2007-12-14 2016-11-15 Labogroup S.A.S. Administration de produits alimentaires sous forme d'aerosols
PL2231642T3 (pl) 2008-01-11 2014-04-30 Novartis Ag Pirymidyny jako inhibitory kinazy
CN102124003A (zh) 2008-06-18 2011-07-13 阿斯利康(瑞典)有限公司 作为治疗呼吸系统疾病的β2肾上腺素受体拮抗剂的苯并噁嗪酮衍生物
WO2011061527A1 (fr) 2009-11-17 2011-05-26 Astrazeneca Ab Combinaisons qui comprennent un modulateur du récepteur glucocorticoïde, destinées au traitement de maladies respiratoires
US8637516B2 (en) 2010-09-09 2014-01-28 Irm Llc Compounds and compositions as TRK inhibitors
WO2012034095A1 (fr) 2010-09-09 2012-03-15 Irm Llc Composés et compositions comme inhibiteurs de trk
GB201016912D0 (en) 2010-10-07 2010-11-24 Astrazeneca Ab Novel combination
BR112013021638A2 (pt) 2011-02-25 2016-08-02 Irm Llc "compostos inibidores de trk, seu uso e composições que os compreendem"
JO3192B1 (ar) * 2011-09-06 2018-03-08 Novartis Ag مركب بنزوثيازولون
KR20220119529A (ko) 2016-06-02 2022-08-29 애브비 인코포레이티드 글루코코르티코이드 수용체 작용제 및 이의 면역접합체
ES2877659T3 (es) 2017-12-01 2021-11-17 Abbvie Inc Agonista del receptor de glucocorticoides y sus inmunoconjugados

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1999009018A1 (fr) * 1997-08-14 1999-02-25 Kirin Beer Kabushiki Kaisha DERIVES DE BENZOTHIAZOLONE PRESENTANT UNE ACTIVITE SELECTIVE D'AGONISTE DU RECEPTEUR β2
AR040962A1 (es) * 2002-08-09 2005-04-27 Novartis Ag Compuestos derivados de tiazol 1,3-2-ona, composicion farmaceutica y proceso de preparacion del compuesto

Also Published As

Publication number Publication date
PE20050692A1 (es) 2005-11-15
CA2552938A1 (fr) 2005-08-18
CN1917875A (zh) 2007-02-21
WO2005074924A1 (fr) 2005-08-18
AU2005210140A1 (en) 2005-08-18
TW200536533A (en) 2005-11-16
RU2006132195A (ru) 2008-03-20
EP1715860A1 (fr) 2006-11-02
BRPI0507544A (pt) 2007-06-12
JP2007522141A (ja) 2007-08-09
KR20060127974A (ko) 2006-12-13
AR047962A1 (es) 2006-03-15

Similar Documents

Publication Publication Date Title
GB0410712D0 (en) Organic compounds
GB0409921D0 (en) Organic compounds
GB0403038D0 (en) Organic compounds
GB0407723D0 (en) Organic compounds
GB0401334D0 (en) Organic compounds
GB0405289D0 (en) Organic compounds
GB0402797D0 (en) Organic compounds
GB0404434D0 (en) Organic compounds
GB0408078D0 (en) Organic compounds
GB0400781D0 (en) Organic compounds
GB0406515D0 (en) Organic compounds
GB0403254D0 (en) Organic compounds
GB0403115D0 (en) Organic compounds
GB0409236D0 (en) Organic compounds
GB0405723D0 (en) Organic compounds
GB0406240D0 (en) Organic compounds
GB0407468D0 (en) Organic compounds
GB0407607D0 (en) Organic compounds
GB0405898D0 (en) Organic compounds
GB0405034D0 (en) Organic compounds
GB0409602D0 (en) Organic compounds
GB0402100D0 (en) Organic compounds
GB0410264D0 (en) Organic compounds
GB0400177D0 (en) Organic compounds
GB0406737D0 (en) Organic compounds

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)